Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00293930 · ClinicalTrials.gov registry record · Phase 3
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
A Phase 3 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 645
- Enrollment target
NCT00293930 is a Phase 3 study that has completed, run by Astellas Pharma. The registered enrollment target is 645 participants.
The verdict
NCT00293930, a Phase 3 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 645 participants
- Enrollment target
Study Summary
A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis
Interventions
- DRUG Tacrolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 645 participants |
| Est. Completion | 2006-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00293930
The ClinicalTrials.gov registry entry for NCT00293930 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 645 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tacrolimus is the first listed.
NCT00293930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00293930 about?
NCT00293930 is a clinical study titled "A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis". A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis
What is the current status of trial NCT00293930?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 645 participants. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00293930?
The interventions under investigation include: Tacrolimus (DRUG).
Who is sponsoring clinical trial NCT00293930?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.